As recently reported, multiple sclerosis patients in the U.S. (age 22+) can with a prescription now obtain the portable neuromodulation stimulator (PoNS) device, which could improve walking ability in individuals with mild to moderate disease activity.1
8 Comments
Once again, there’s more clinical evidence that dietary interventions can positively impact the course of many autoimmune diseases, including multiple sclerosis (MS).
|
AuthorSuzanne Gazda M.D. Archives
June 2022
Categories |